CVS Health CVS
$83.85 +$2.52 (+3.10%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $84.15 +0.36%
Open$80.70
Prev close$81.33
Day range$80.69 – $84.38
Volume16.10M
Market cap$107.28B
P/E (TTM)9.7
Dividend yield3.17%
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Institutional ownership90.6%+0.14 pts vs. prior quarter
Institutions holding2,316-44 vs. prior quarter
Insider trades (recent)30 buys / 20 sellsNet buying
Short interest1.27% of floatDays to cover 1.6 · as of 15 Oct 2026
Short-sale volume share6.0%5-day average of daily volume
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$281.35M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 34.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 1.46% to 1.27% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +2,036,280 | 0.3% |
| Managed Account Advisors LLC | Mutual Fund | 2026/Q3 | +12,540,195 | 1.2% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +11,233,381 | 2.6% |
| GQG Partners, LLC | Mutual Fund | 2026/Q3 | +7,923,888 | 0.6% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +3,863,675 | 0.7% |
| Viking Global Investors LP | Hedge Fund | 2026/Q3 | +3,663,361 | 0.3% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +2,459,533 | 0.2% |
| Capital Research | Mutual Fund | 2026/Q3 | +2,119,421 | 9.1% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,961,032 | 0.2% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +1,925,610 | 0.2% |
| Sparinvest SA (Luxembourg) | Mutual Fund | 2026/Q3 | +1,739,266 | 0.2% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q3 | +1,685,440 | 0.1% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Private Company | 2026/Q3 | +1,507,326 | 0.4% |
| BB&T Trust | Mutual Fund | 2026/Q3 | +1,463,437 | 0.1% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +1,311,446 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 25 Jun 2026 | James Clark | Chief Accounting Officer | Sale to Issuer | -454 | $90.98 | 27,606 |
| 30 May 2026 | Amy Compton-Phillips | Chief Medical Officer | Sale to Issuer | -7,618 | $90.98 | 9,592 |
| 30 May 2026 | Brian Newman | Chief Financial Officer | Sale to Issuer | -2,478 | $90.98 | 3,038 |
| 20 May 2026 | Roger Farah | Former Executive Director | Intent to Sell (Form 144) | -2,817 | $93.68 | – |
| 20 May 2026 | Glenview Capital Management, LLC | Open Market Derivative Dispositi | -378,000 | $58.29 | – | |
| 20 May 2026 | Fernando Aguirre | Independent Director | Sale to Issuer | -32,000 | $93.78 | 10,513 |
| 20 May 2026 | Glenview Capital Management, LLC | Open Market Disposition | -3,372,000 | $96.28 | 4,824,799 | |
| 19 May 2026 | Fernando Aguirre | Independent Director | Intent to Sell (Form 144) | -32,000 | $94.69 | – |
| 13 May 2026 | Douglas Shulman | Independent Director | Other Derivative Acquisition | +1,447 | – | 1,448 |
| 13 May 2026 | J. Kirby | Independent Director | Other Acquisition | +1,447 | $97.15 | 14,434 |
| 13 May 2026 | Lawrence Robbins | Former Independent Director | Other Derivative Acquisition | +1,930 | – | 10,148 |
| 13 May 2026 | Anne Finucane | Independent Director | Other Derivative Acquisition | +1,544 | – | 18,355 |
| 13 May 2026 | C. Brown | Independent Director | Other Acquisition | +1,544 | $97.15 | 129,316 |
| 13 May 2026 | Alecia DeCoudreaux | Independent Director | Other Derivative Acquisition | +1,447 | – | 42,182 |
| 13 May 2026 | Guy Sansone | Independent Director | Other Acquisition | +1,447 | $97.15 | 15,106 |
| 13 May 2026 | Fernando Aguirre | Independent Director | Other Acquisition | +1,563 | $97.15 | 43,181 |
| 13 May 2026 | Jeffrey Balser | Independent Director | Other Acquisition | +2,058 | $97.15 | 15,717 |
| 13 May 2026 | Leslie Norwalk | Director | Other Acquisition | +1,447 | $97.15 | 7,376 |
| 13 May 2026 | John Gallina | Independent Director | Other Derivative Acquisition | +1,447 | – | 1,448 |
| 13 May 2026 | Michael Mahoney | Lead Independent Director | Other Derivative Acquisition | +1,737 | – | 6,429 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 16,193,404 | 1.3% | 1.6 |
| 30 Sep 2026 | 16,470,151 | 1.3% | 1.7 |
| 15 Sep 2026 | 16,123,980 | 1.3% | 3.1 |
| 31 Aug 2026 | 18,114,651 | 1.4% | 2.8 |
| 14 Aug 2026 | 16,823,735 | 1.3% | 1.8 |
| 31 Jul 2026 | 18,676,470 | 1.5% | 2.4 |
No comments yet — be the first to weigh in on CVS.
Sign in to join the discussion.